First Time Loading...

PYC Therapeutics Ltd
ASX:PYC

Watchlist Manager
PYC Therapeutics Ltd Logo
PYC Therapeutics Ltd
ASX:PYC
Watchlist
Price: 0.105 AUD 5% Market Closed
Updated: May 16, 2024

PYC Therapeutics Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PYC Therapeutics Ltd
Cost of Revenue Peer Comparison

Comparables:
IMM
MSB
CSL
CUV
TLX

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
PYC Therapeutics Ltd
ASX:PYC
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immutep Ltd
ASX:IMM
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mesoblast Ltd
ASX:MSB
Cost of Revenue
-$21.7m
CAGR 3-Years
15%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
CSL Ltd
ASX:CSL
Cost of Revenue
-$6.9B
CAGR 3-Years
-19%
CAGR 5-Years
-14%
CAGR 10-Years
-11%
Clinuvel Pharmaceuticals Ltd
ASX:CUV
Cost of Revenue
AU$8.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Telix Pharmaceuticals Ltd
ASX:TLX
Cost of Revenue
-AU$188.2m
CAGR 3-Years
-353%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also